Skip to content
28 May 2026

How to Stop the Progression of Arthritis: What the Evidence Actually Says

How to stop the progression of arthritis?

You can slow arthritis progression significantly. In inflammatory types like rheumatoid arthritis and psoriatic arthritis, you can stop measurable joint damage almost completely.

The key is acting early and using the right treatment for your type. Waiting more than 6 to 12 months after symptoms start increases the risk of permanent joint damage that cannot be reversed. For osteoarthritis, complete reversal isn't realistic, but slowing it down enough to preserve function and delay joint replacement is absolutely achievable.

The type of arthritis you have changes everything about how you approach this.

What Type of Arthritis Are You Dealing With?

Arthritis isn't one disease. The two most common types work through completely different mechanisms, and what stops one does almost nothing for the other.

Inflammatory arthritis includes rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis. Your immune system attacks your own joints. This causes swelling, warmth, stiffness, and over time, bone erosion that shows up on X-rays.

Osteoarthritis involves cartilage breakdown. For a long time it was called a wear-and-tear disease, but research now shows it's actually an inflammatory condition affecting the whole joint, not just the cartilage surface.

How to Stop the Progression of Arthritis When It Is Inflammatory

This is where the evidence is strongest. Biologic medications and targeted synthetic disease-modifying drugs have clear, measurable proof that they slow joint destruction.

In early rheumatoid arthritis, combining adalimumab with methotrexate was significantly better than either drug alone. In the PREMIER study, 62% of patients on combination therapy reached ACR50 response, and radiographic progression was substantially lower at one year compared to monotherapy. That means less bone erosion, less joint space narrowing, measurable on X-ray.

For psoriatic arthritis, secukinumab, which blocks a protein called IL-17A, showed clear inhibition of radiographic progression at 24 weeks compared to placebo. Over two years, joint damage scores stayed near zero across dosing groups. That's not symptom relief. That's structural protection.

In axial spondyloarthritis, both secukinumab and an adalimumab biosimilar showed similar ability to limit spinal progression over 104 weeks in high-risk patients.

What this means practically:

  1. Get diagnosed and start a disease-modifying drug within 3 to 6 months of symptoms starting
  2. For rheumatoid arthritis, combination therapy with a biologic plus methotrexate outperforms either alone
  3. Reassess every 3 months and adjust until you reach remission or low disease activity
  4. Get X-rays every 6 to 12 months to confirm structural protection is happening

The single biggest mistake people make is waiting. Symptoms come and go early on, so it feels manageable. But joint erosion is happening silently during that window.

Does Arthritis Come and Go?

Yes. And this is exactly what makes it dangerous to ignore.

Inflammatory arthritis often flares and then quiets down. You feel fine for weeks, then symptoms return. This pattern tricks people into thinking the disease is resolving on its own. It's not. Between flares, the underlying inflammation continues damaging joint tissue, just at a lower level.

Osteoarthritis also fluctuates. Pain can be worse on some days and barely noticeable on others depending on activity, weather, and inflammation levels. But the structural changes in the joint are cumulative and don't reverse when symptoms ease.

The gap between how you feel and what's happening structurally is one of the most important things to understand about arthritis. Pain is a poor measure of disease activity, especially in osteoarthritis.

What Causes an Arthritis Flare-Up?

Flares in inflammatory arthritis are usually triggered by one of these:

  • Stopping or reducing medication too early
  • Infection, which activates the immune system broadly
  • Physical or emotional stress, which raises inflammatory markers
  • Overexertion of an already inflamed joint
  • Poor sleep, which disrupts immune regulation

In osteoarthritis, flares are more often driven by mechanical load, meaning too much activity on a damaged joint, combined with local inflammation. Synovitis (inflammation of the joint lining) plays a bigger role in osteoarthritis flares than most people realize.

Flares aren't random. They follow patterns, and identifying your personal triggers is one of the most practical things you can do to reduce their frequency.

How to Stop the Progression of Arthritis Without Medication

For inflammatory arthritis, lifestyle changes alone won't stop structural progression. The evidence is clear on this. But they significantly improve how well medications work and reduce flare frequency.

For osteoarthritis, lifestyle changes are the primary intervention because proven disease-modifying drugs for OA in humans are still limited.

Here's what has actual evidence behind it:

Weight Loss

Losing 5 to 10% of body weight if you're overweight reduces mechanical load on knee and hip joints and lowers systemic inflammation. This is one of the few interventions with consistent evidence for slowing osteoarthritis symptoms and possibly structural progression.

Exercise

Quadriceps strengthening reduces load on the knee joint. Low-impact aerobic exercise like swimming, cycling, and walking maintains joint mobility without adding compressive stress. Movement protects joints. Avoiding movement accelerates deterioration.

People who stayed active, even with pain, maintained function far longer than those who rested. The fear of making it worse by moving is usually wrong.

Diet and Inflammation

A diet high in processed foods, refined sugar, and seed oils drives systemic inflammation. Reducing these and increasing omega-3 fatty acids from fish, vegetables, and whole foods lowers inflammatory markers. This doesn't replace medication in inflammatory arthritis, but it creates a better biological environment for treatment to work.

Sleep

Poor sleep raises inflammatory cytokines. Sleep is consistently underrated as a factor in arthritis management. Getting 7 to 9 hours of quality sleep reduces pain sensitivity and supports immune regulation.

Joint-Preserving Surgery

For osteoarthritis with focal cartilage damage or joint misalignment, surgery before age 50 to 55 can preserve the joint and delay or prevent total replacement. This is a structural intervention, not a last resort. Waiting until the joint is completely destroyed limits surgical options.

Does Arthritis in the Knee Ever Go Away?

Osteoarthritis in the knee doesn't go away. Cartilage doesn't regenerate in any meaningful way once it's damaged. But the rate of progression varies enormously between people, and many people with knee osteoarthritis maintain good function for decades with the right management.

Inflammatory arthritis in the knee can go into remission with treatment. Remission means no active inflammation, no progression on imaging, and minimal or no symptoms. This is a realistic goal with modern biologics, especially when treatment starts early.

The distinction matters. For osteoarthritis, the goal is preservation and slowing. For inflammatory arthritis, the goal is remission and structural protection.

What Is Actually Being Researched Right Now for Osteoarthritis

Two compounds show real promise in preclinical research, though neither is standard clinical practice yet.

Metformin, the diabetes drug, significantly reduced cartilage degeneration in mice after joint injury. It works by activating a cellular energy sensor called AMPK, which reduces inflammation and cartilage breakdown. In people with osteoarthritis and metabolic syndrome, metformin may offer benefit, but this is still investigational.

Halofuginone reduced cartilage and bone deterioration in rodent models by blocking TGF-beta activity and abnormal blood vessel formation in the bone beneath the cartilage. This is early research, but it points toward the subchondral bone as a target, not just the cartilage surface.

This research tells us that osteoarthritis is a whole-joint disease with multiple biological targets. The old model of just replacing worn cartilage is being replaced by a more complete picture of what's actually breaking down.

How to Monitor Whether Arthritis Is Progressing

You can't rely on pain alone. Pain and structural damage don't track closely in osteoarthritis. You can have significant cartilage loss with minimal pain, or significant pain with minimal structural change.

For inflammatory arthritis, get X-rays every 6 to 12 months when disease is active or treatment is being adjusted. Blood markers like CRP and ESR track inflammation but not structural damage directly.

For osteoarthritis, X-rays every 1 to 2 years for symptomatic joints give you a baseline and show whether joint space is narrowing over time.

MRI gives more detail on cartilage, bone marrow lesions, and synovitis, and is useful when X-rays look normal but symptoms are significant.

Three Things Most People Get Wrong About Stopping Arthritis Progression

  1. Waiting for pain to guide treatment decisions. Pain is a lagging indicator. By the time pain is severe, structural damage is often already significant. Treat based on inflammation markers and imaging, not just how you feel.
  2. Treating all arthritis the same way. Anti-inflammatory supplements and lifestyle changes that help osteoarthritis do almost nothing to stop bone erosion in rheumatoid arthritis. The type determines the treatment.
  3. Stopping medication when symptoms improve. This is one of the most common causes of flares and accelerated progression in inflammatory arthritis. Remission is maintained by continuing treatment, not a sign that you can stop it.

FAQ

Can you reverse arthritis damage?

No. Existing joint damage, whether cartilage loss in osteoarthritis or bone erosion in inflammatory arthritis, doesn't reverse. The goal is stopping further damage and preserving what remains.

Is walking good or bad for arthritis?

Walking is good for most arthritis. It maintains joint mobility, strengthens surrounding muscles, and reduces stiffness. The exception is walking on a severely damaged joint without any support or management, which can accelerate mechanical wear.

What is the fastest way to reduce arthritis inflammation?

For inflammatory arthritis, biologics and corticosteroids reduce inflammation fastest. For osteoarthritis flares, ice, rest, NSAIDs, and reducing load on the joint are the most immediate options. Long-term, the anti-inflammatory lifestyle changes above reduce baseline inflammation consistently.

Does cold weather make arthritis worse?

Many people report more pain and stiffness in cold weather. The mechanism isn't fully established, but changes in barometric pressure and reduced physical activity in cold months are likely contributors. This is a symptom trigger, not a structural progression factor.

Can diet alone stop arthritis from getting worse?

For osteoarthritis, diet combined with weight management and exercise is the primary non-surgical intervention. For inflammatory arthritis, diet alone can't stop immune-mediated joint destruction. It supports treatment but doesn't replace it.

How do I know if my arthritis is getting worse?

Increasing stiffness lasting more than 30 minutes in the morning, new joints becoming affected, reduced range of motion, and worsening on imaging are the main signs. Don't rely on pain alone as your measure.

Armstrong Lazenby
About the author

Armstrong Lazenby

BSc (Human Nutrition) registered nutritionist. Bachelor of Science (Exercise Science major) Master of Sports Medicine.

Connect on LinkedIn →

Sources

  1. Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H, et al. (2015) "Osteoarthritis" Lancet (London, England). PMID: 25748615
  2. Mobasheri A, Batt M (2016) "An update on the pathophysiology of osteoarthritis" Annals of physical and rehabilitation medicine. PMID: 27546496
  3. Li J, Zhang B, Liu WX, Lu K, Pan H, Wang T, et al. (2020) "Metformin limits osteoarthritis development and progression through activation of AMPK signalling" Annals of the rheumatic diseases. PMID: 32156705
  4. Mease P, van der Heijde D, Landewé R, Mpofu S, Rahman P, Tahir H, et al. (2018) "Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study" Annals of the rheumatic diseases. PMID: 29550766
  5. Mease PJ, Landewé R, Rahman P, Tahir H, Singhal A, Boettcher E, et al. (2021) "Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTURE 5 study" RMD open. PMID: 34330846
  6. Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, et al. (2006) "The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment" Arthritis and rheumatism. PMID: 16385520
  7. Baraliakos X, Østergaard M, Poddubnyy D, van der Heijde D, Deodhar A, Machado PM, et al. (2024) "Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head-to-Head Randomized Phase IIIb Study" Arthritis & rheumatology (Hoboken, N.J.). PMID: 38556921
  8. Cui Z, Crane J, Xie H, Jin X, Zhen G, Li C, et al. (2016) "Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone" Annals of the rheumatic diseases. PMID: 26470720